05:22 PM EDT, 05/09/2024 (MT Newswires) -- Pascal Deschatelets, Chief Scientific Officer, on May 08, 2024, sold 78,907 shares in Apellis Pharmaceuticals ( APLS ) for $3,341,848. Following the Form 4 filing with the SEC, Deschatelets has control over a total of 1,115,983 shares of the company, with 1,115,983 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1492422/000112760224014811/xslF345X03/form4.xml

Price: 42.66, Change: +0.14, Percent Change: +0.33